Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |